Structured management strategy versus usual care for gastroesophageal reflux disease: Rationale for pooled analysis of five European cluster-randomized trials

Therapeutic Advances in Gastroenterology

Volumn 4, Issue 1, 2011, Pages 11-26

  Ponce, Julio ^a   Agréus, Lars ^b   Tabaglio, Erminio ^c   Gschwantler, Michael ^d   Güallar, Eliseo ^e   Tafalla, Mónica ^f   Nuevo, Javier ^f   Hatlebakk, Jan G ^g  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Societ Italiana Medicina Generale   (Italy)

^d WILHELMINEN HOSPITAL   (Austria)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f ASTRAZENECA   (United Kingdom)

^g HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Gastroesophageal reflux disease; GerdQ; Pooled analysis

Indexed keywords

ESOMEPRAZOLE;

ADULT; AGED; ARTICLE; AUSTRIA; CONTROL STRATEGY; CONTROLLED STUDY; ENDOSCOPY; EUROPE; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CARE UTILIZATION; HEALTH STATUS; HEARTBURN; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NORWAY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT REFERRAL; PH; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PRODUCTIVITY; QUESTIONNAIRE; REIMBURSEMENT; RESOURCE MANAGEMENT; SPAIN; SWEDEN;

EID: 80052367622     PISSN: 1756283X     EISSN: 17562848     Source Type: Journal    
DOI: 10.1177/1756283X10387060     Document Type: Article

References (12)

1. Armstrong D. Marshall J.K. Chiba N. Enns R. Fallone C.A. Fass R. et al. (2005) Canadian Consensus Conference on the management of gastroesophageal reflux disease in disease in adults - update 2004. Can J Gastroenterol 19: 15–35.
2. de Vault K.R. Castell D.O. (2005) Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 100: 190–200.
3. Gisbert J.P. Cooper A. Karagiannis D. Hatlebakk J. Agreus L. Jablonowski H. et al. (2009a) Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study. Health Qual Life Outcomes 7: 90–90.
4. Gisbert J.P. Cooper A. Karagiannis D. Hatlebakk J. Agreus L. Jablonowski H. et al. (2009b) Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting. Health Qual Life Outcomes 7: 60–60.
5. Howden C.W. Henning J.M. Huang B. Lukasik N. Freston J.W. (2001) Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies. Am J Gastroenterol 96: 1704–1710.
6. Inadomi J.M. Jamal R. Murata G.H. Hoffman R.M. Lavezo L.A. Vigil J.M. et al. (2001) Step-down management of gastroesophageal reflux disease. Gastroenterology 121: 1095–1100.
7. Jones R. Junghard O. Dent J. Vakil N. Halling K. Wernersson B. et al. (2009) Development of the Gerd Q., a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther 30: 1030–1038.
8. Jones R. Liker H.R. Ducrotté P. (2007) Relationship between symptoms, subjective well-being and medication use in gastro-oesophageal reflux disease. Int J Clin Pract 61: 1301–1307.
9. Kahrilas P.J. Shaheen N.J. Vaezi M.F. (2008) American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology 135: 1392–1413.
10. Toghanian S. Wahlqvist P. Johnson D.A. Bolge S.C. Liljas B. (2010) The burden of disrupting gastro-oesophageal reflux disease: a database study in US and European cohorts. Clin Drug Investig 30: 167–178.
11. Vakil N. van Zanten S.V. Kahrilas P. Dent J. Jones R. (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101: 1900–1920.
12. Wiklund I. (2004) Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis 22: 108–114.